Scribble acts as an oncogene in Eμ-myc-driven lymphoma

被引:0
|
作者
E D Hawkins
J Oliaro
K M Ramsbottom
A Newbold
P O Humbert
R W Johnstone
S M Russell
机构
[1] Cancer Immunology Program,Sir Peter MacCallum Department of Oncology
[2] Peter MacCallum Cancer Centre,Department of Pathology
[3] The University of Melbourne,Department of Biochemistry and Molecular Biology
[4] Melbourne,undefined
[5] Victoria,undefined
[6] Australia,undefined
[7] Cancer Therapeutics Programs,undefined
[8] Peter MacCallum Cancer Centre,undefined
[9] Cell Cycle and Cancer Genetics Laboratory,undefined
[10] Peter MacCallum Cancer Centre,undefined
[11] The University of Melbourne,undefined
[12] Melbourne,undefined
[13] Victoria,undefined
[14] Australia,undefined
[15] The University of Melbourne,undefined
[16] Melbourne,undefined
[17] Victoria,undefined
[18] Cell cycle and Cancer Genetics Laboratory,undefined
[19] Peter MacCallum Cancer Centre,undefined
[20] Centre for Micro-Photonics,undefined
[21] Swinburne University of Technology,undefined
[22] 9Current address: Imperial College London,undefined
[23] Sir Alexander Fleming Building,undefined
[24] SW72AZ,undefined
[25] London,undefined
[26] UK.,undefined
来源
Oncogene | 2016年 / 35卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Scribble complex proteins maintain apicobasal polarity, regulate cell fate determination and function as tumour suppressors in epithelial tissue. Despite evidence that the function of Scribble is maintained in the lymphocyte lineage, we still understand little about its role as a tumour suppressor in haematological malignancies. Using the Eμ-myc model of Burkitt’s lymphoma we investigated the role of Scribble in lymphomagenesis. We found that contrary to its well-documented tumour suppressor role in epithelial tissue, loss of Scribble expression delayed the expansion of peripheral B cells and delayed the onset of Eμ-myc-driven lymphoma. This was despite upregulated ERK phosphorylation levels in Scribble-deficient tumours, which are associated with loss of Scribble expression and the development of more aggressive Burkitt’s lymphoma. Interestingly, the developmental stage of lymphoma was unaffected by Scribble expression challenging any role for Scribble in fate determination in the haematopoetic lineage. These data provide evidence for oncogenic properties of Scribble in Myc-driven B-cell lymphomagenesis, reinforcing recent findings that overexpression of a mutant form of Scribble can act as an oncogene in epithelial cells. Our results support the growing appreciation that the tumour regulatory functions of Scribble, and other polarity protein family members, are context dependent.
引用
收藏
页码:1193 / 1197
页数:4
相关论文
共 50 条
  • [21] Mnt modulates Myc-driven lymphomagenesis
    Kirsteen J Campbell
    Cassandra J Vandenberg
    Natasha S Anstee
    Peter J Hurlin
    Suzanne Cory
    Cell Death & Differentiation, 2017, 24 : 2117 - 2126
  • [22] An Animal Model of MYC-Driven Medulloblastoma
    Pei, Yanxin
    Moore, Colin E.
    Wang, Jun
    Tewari, Alok K.
    Eroshkin, Alexey
    Cho, Yoon-Jae
    Witt, Hendrik
    Korshunov, Andrey
    Read, Tracy-Ann
    Sun, Julia L.
    Schmitt, Earlene M.
    Miller, C. Ryan
    Buckley, Anne F.
    McLendon, Roger E.
    Westbrook, Thomas F.
    Northcott, Paul A.
    Taylor, Michael D.
    Pfister, Stefan M.
    Febbo, Phillip G.
    Wechsler-Reya, Robert J.
    CANCER CELL, 2012, 21 (02) : 155 - 167
  • [23] Therapeutic targets for MYC-driven cancers
    Laffman-Johnson, Elise
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 92 (03) : 272 - 272
  • [24] ID3 Loss In Vivo Synergizes with MYC-Driven Oncogenesis in Burkitt Lymphoma
    Love, Cassandra
    Remple, Rachel
    Li, Guojie
    Dave, Sandeep
    BLOOD, 2015, 126 (23)
  • [25] BCL-W makes only minor contributions to MYC-driven lymphoma development
    Diepstraten, Sarah T.
    La Marca, John E.
    Chang, Catherine
    Young, Savannah
    Strasser, Andreas
    Kelly, Gemma L.
    ONCOGENE, 2023, 42 (37) : 2776 - 2781
  • [26] Phosphoglycerate Dehydrogenase Is Required for Germinal Center Formation and Is a Therapeutic Target in MYC-driven Lymphoma
    D'Avola, Annalisa
    Legrave, Nathalie
    Tajan, Mylene
    Chakravarty, Probir
    Shearer, Ryan
    King, Hamish
    Cheung, Eric
    Clear, Andrew James
    Gunawan, Arief Suryono
    Zhang, Lingling
    James, Louisa
    MacRae, James
    Gribben, John
    Calado, Dinis Pedro
    Vousden, Karen
    Riches, John C.
    BLOOD, 2021, 138
  • [27] BCL-W makes only minor contributions to MYC-driven lymphoma development
    Sarah T. Diepstraten
    John E. La Marca
    Catherine Chang
    Savannah Young
    Andreas Strasser
    Gemma L. Kelly
    Oncogene, 2023, 42 : 2776 - 2781
  • [28] Tuberous sclerosis complex is required for tumor maintenance in MYC-driven Burkitt's lymphoma
    Hartleben, Goetz
    Mueller, Christine
    Kraemer, Andreas
    Schimmel, Heiko
    Zidek, Laura M.
    Dornblut, Carsten
    Winkler, Rene
    Eichwald, Sabrina
    Kortman, Gertrud
    Kosan, Christian
    Kluiver, Joost
    Petersen, Iver
    van den Berg, Anke
    Wang, Zhao-Qi
    Calkhoven, Cornelis F.
    EMBO JOURNAL, 2018, 37 (21):
  • [29] Myc-Driven Glycolysis Is a Therapeutic Target in Glioblastoma
    Tateishi, Kensuke
    Iafrate, A. John
    Ho, Quan
    Curry, William T.
    Batchelor, Tracy T.
    Flaherty, Keith T.
    Onozato, Maristela L.
    Lelic, Nina
    Sundaram, Sudhandra
    Cahill, Daniel P.
    Chi, Andrew S.
    Wakimoto, Hiroaki
    CLINICAL CANCER RESEARCH, 2016, 22 (17) : 4452 - 4465
  • [30] PHGDH is required for germinal center formation and is a therapeutic target in MYC-driven lymphoma (vol 132, e153436, 2022)
    D'Avola, Annalisa
    Legrave, Nathalie
    Tajan, Mylene
    Chakravarty, Probir
    Shearer, Ryan L.
    King, Hamish W.
    Kluckova, Katarina
    Cheung, Eric C.
    Clear, Andrew J.
    Gunawan, Arief S.
    Zhang, Lingling
    James, Louisa K.
    MacRae, James I.
    Gribben, John G.
    Calado, Dinis P.
    Vousden, Karen H.
    Riches, John C.
    JOURNAL OF CLINICAL INVESTIGATION, 2024, 134 (04):